Key result
Venous thromboembolism is a chronic illness with a high risk of recurrence (21.5% after a first event) and mortality (6% within 1 month), requiring appropriate preventative and treatment measures.
VTE should be considered a chronic illness with significant recurrence risk, requiring proactive identification and management by healthcare providers.
Answers are grounded in this paper and cite their sources.
VTE warrants chronic management models in practice; leaves open optimal long-term prevention strategies for future trials.
Deep vein thrombosis (DVT) is a common disorder frequently seen in both the inpatient and outpatient settings. DVT increases the risk of pulmonary embolism, a potentially fatal complication. These 2 conditions--DVT and pulmonary embolism--comprise venous thromboembolism (VTE), which is a major and often unrecognized cause of morbidity and mortality in hospitalized and ambulatory patients. Acquired risk factors include smoking, obesity, stasis (such as long-term travel), hypercoagulability, recent surgery, trauma, or hospitalizations. In addition, inherited or innate disorders that pose risk include increasing age and personal or family history of VTE.After a first episode of VTE, the risk for recurrent episodes of a DVT is elevated: 21.5% after a first event and 27.9% after a second. And, the risk of recurrence varies with time, with highest risk occurring during the first 6 to 12 months after the event. Death occurs in 6% of DVT cases within 1 month of diagnosis. Once a DVT occurs, the risk recurrence never resolves to zero; therefore, VTE should be considered a chronic illness rather than a short-term condition. As a key member of the healthcare team, the role a nurse practitioner is to identify patients at risk for VTE and institute appropriate preventative/treatment measures. By doing so, morbidity and mortality from this common disorder can be minimized.
No takes yet. Share an insight, caveat, or question.
Carol M. Mason (2009) conducted a review in Venous Thromboembolism. Venous thromboembolism is a chronic illness with a high risk of recurrence (21.5% after a first event) and mortality (6% within 1 month), requiring appropriate preventative and treatment measures.
Synapse has enriched 10 related papers. Consider them for comparative context: